Papua New Guinea
Papua New Guinea (PNG) has been a recipient country of the Global Fund since 2004 and has been disbursed over US$315.2 million for HIV, TB and malaria.
As of the Audit Report; Global Fund Grants in Papua New Guinea released in September 2019, the Global Fund is providing approximately 42% of the total funding for malaria, 29% for tuberculosis and 10% for HIV for the period 2018 – 2020. Regarding progress against the three diseases, there has been a recent surge in malaria prevalence (from 1% to 7%). For HIV, progress has been made in removing barriers in access to services, and in strengthening and coordinating civil society organizations. PNG has the highest number of new tuberculosis cases in the Pacific Region and the 30th highest globally but a lack of accurate data on the actual TB burden in the country is hampering programmatic impact. At the same time drug-resistant TB, particularly in PNG, could potentially lead to a regional health security issue as reported in the Regional Impact Report on Global Fund’s Investments in the Pacific Region.
About the action
The action in Papua New Guinea is led by National Advocacy KP Consortium with the support of the following partners.